Guy's and St Thomas' NHS Foundation Trust at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Guy's and St Thomas' NHS Foundation Trust brings 8 presentations to ASH 2026 in New Orleans. Its program centres on myeloproliferative neoplasms, especially myelofibrosis. Research covers a CALR-specific antibody, elritercept and momelotinib, plus sessions on drug resistance and progression.
| Organization | ASH 2026 Attendance |
|---|---|
Guy's and St Thomas' NHS Foundation Trust London, United Kingdom | |
NHS trust running Guy's and St Thomas' hospitals in London, with a large clinical haematology service. | Symposium Fri Dec 11 3:00pm–6:00pm Cases and Conversations: Applying Emerging Evidence to Real-World Care in Myeloproliferative Neoplasms Choosing among new myeloproliferative neoplasm drugs, including Janus kinase and telomerase inhibitors, hepcidin mimetics, and calreticulin-targeted antibodies. Session Sat Dec 12 9:30am–10:45am Addressing Resistance and Progression in Myeloproliferative Diseases Why myeloproliferative neoplasms persist and progress despite therapy, from clone growth and inflammation to drug resistance, and new mutation-targeted treatments. Talk Sat Dec 12 9:30am–10:45am Mutation-Targeted Therapies in MPN: A New Dawn? New treatments aimed at mutant calreticulin in bone marrow cancers, newer drugs blocking the same growth signal, and trial endpoints that capture disease change. Oral Sat Dec 12 4:00pm–5:30pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at Guy's and St Thomas' NHS Foundation Trust
Tell us what you sell and we’ll find the people at Guy's and St Thomas' NHS Foundation Trust most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction